News in brief - November 2014

• Glycopyrronium bromide 1mg and 2mg tablets are now available as an add-on treatment for peptic ulcers.
• GranuPAS (para-aminosalicylic acid) has been launched for use in combination with other drugs to treat multidrug-resistant TB where other agents cannot be used owing to resistance or intolerance.
• A new controlled-release misoprostol vaginal delivery system (Mysodelle) has been launched for the induction of labour from 36 weeks' gestation in women with an unfavourable cervix.
• Dexamethasone 4mg/ml injection has been replaced by dexamethasone 3.8mg/ml solution for injection; as a result, the dilutions, storage conditions, presentation and packaging have changed.
• Novartis has announced the discontinuation of Tegretol Chewtabs (carbamazepine). Selection of an alternative medication should be a clinical decision based on the individual patient's history.

Follow MIMS on Twitter

Sign up for MIMS bulletins